Overview
Nolan Priedigkeit, MD, PhD is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Instructor of Medicine at Harvard Medical School. Clinically, he specializes in breast cancer and his research aims to merge computational and genomic sciences with technology development to make an impact on how we understand and treat metastatic disease. He received dual MD/PhD degrees from the University of Pittsburgh-Carnegie Mellon University Medical Scientist Training Program where his thesis applied translational genomics to discover novel drug targets in advanced breast cancers. He completed an internal medicine residency at Brigham & Women’s Hospital, a medical oncology fellowship at Dana-Farber/Mass General Brigham, and currently leads multidisciplinary research projects at the Broad Institute of MIT & Harvard focused exclusively on breast cancer. He has been supported by awards from the National Cancer Institute, American Association for Cancer Research, Conquer Cancer Foundation of ASCO, Lubin Family Foundation, and the Susan G. Komen Foundation. He values patient-centered care with a focus on open and transparent communication, generous sharing of research data and ideas, as well as mentorship of trainees in both science and medicine.
Dr. Priedigkeit is highly rated in 3 conditions, according to our data. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Metastatic Brain Tumor.
His clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
Locations
450 Brookline Ave, Boston, MA 02215
Additional Areas of Focus
Dr. Priedigkeit has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Dana-Farber Cancer Institute
Philippe Armand is an Oncologist in Boston, Massachusetts. Dr. Armand is highly rated in 27 conditions, according to our data. His top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Nolan Priedigkeit
Is Dr. Nolan Priedigkeit a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nolan Priedigkeit is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nolan Priedigkeit specialize in?
While Dr. Nolan Priedigkeit is a Oncology, they have specific expertise in Breast Cancer, Inflammatory Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Nolan Priedigkeit participate in research or clinical trials?
Yes. Dr. Nolan Priedigkeit has published 31 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Nolan Priedigkeit's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nolan Priedigkeit accept my insurance?
Dr. Nolan Priedigkeit accepts most major insurance plans, including Anthem BCBS and Capital Blue Cross. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Priedigkeit isAdvanced. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Priedigkeit isAdvanced. Learn about Inflammatory Breast Cancer.
- PIK3CA-Related Overgrowth SpectrumDr. Priedigkeit isAdvanced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Experienced
- Bone TumorDr. Priedigkeit isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Priedigkeit isExperienced. Learn about Brain Tumor.
- Metastatic Brain TumorDr. Priedigkeit isExperienced. Learn about Metastatic Brain Tumor.
- Ovarian CancerDr. Priedigkeit isExperienced. Learn about Ovarian Cancer.